Strategic B2B Supply for Japanese Pharmaceutical Wholesalers & Specialist Clinics Sky High Medex is an established pharmaceutical exporter providing Lonitab 2.5 Tablets to licensed medical wholesalers, private healthcare facilities, and clinical research organizations across Japan. Manufactured by the global leader Cipla, Lonitab 2.5 contains Minoxidilβa potent oral vasodilator utilized in specialized cardiovascular management and advanced clinical dermatology research within the Japanese medical sector.
B2B Order Details:
Minimum Order Quantity (MOQ): 20 Boxes (Strictly Wholesale).
Active Ingredient: Minoxidil 2.5mg.
Manufacturer: Cipla Ltd.
Therapeutic Class: Vasodilator / Antihypertensive.
Format: Oral Tablets.
The Sky High Medex Advantage for the Japanese Market:
Competitive Export Economies: Optimize your procurement budget by sourcing directly from our Indian export hub, offering significant cost efficiencies for bulk Minoxidil requirements in Tokyo, Osaka, and beyond.
Cipla Manufacturing Excellence: Benefit from the world-class quality standards of one of Indiaβs premier pharmaceutical giants, ensuring consistent bioavailability and chemical purity that meets international benchmarks.
Verified Export Authority: We operate with a valid Import-Export Code (IEC) and GST registration, providing a 100% transparent and professional trade trail for Japanese institutional buyers.
Comprehensive Documentation Suite: Every shipment includes the Certificate of Analysis (COA), detailed commercial invoices, and packing lists to support your internal compliance and quality assurance protocols.
Logistics & Japan Customs Support: While Japanese importers are responsible for domestic customs clearance and ensuring adherence to PMDA (Pharmaceuticals and Medical Devices Agency) guidelines for their specific institutional use, Sky High Medex handles all Indian export formalities with precision. We offer reliable air-freight shipping to major Japanese hubs, including Tokyo (NRT/HND) and Osaka (KIX).
Technical Insight & Clinical Applications: Lonitab 2.5 is an oral formulation of Minoxidil designed to act on the peripheral vasculature. In the regional clinical and research context, it is recognized for:
Systemic Vasodilation: Directly relaxes the smooth muscle in the walls of the blood vessels, effectively reducing peripheral resistance.
Specialized Management: Historically utilized in professional protocols for the treatment of severe or refractory hypertension under strict specialist supervision.
Dermatological Research: Increasingly recognized in Japan for its utility in clinical studies regarding low-dose oral Minoxidil for specific hair restoration and androgenetic alopecia protocols.
Pharmacological Stability: The 2.5mg formulation by Cipla is noted for its high stability and reliable therapeutic index across diverse research settings.
π
π¦ Request a Wholesale Quote for JapanContact our dedicated export desk for current batch availability and tiered bulk pricing.
WhatsApp: +91 9270847472
Email: skyhighmedex@gmail.com
Location: Nagpur Export Hub / International Service Desk